Beauty Health Q2 2024 GAAP EPS $(0.10) Misses $(0.05) Estimate, Sales $90.600M Miss $98.770M Estimate
Portfolio Pulse from Benzinga Newsdesk
Beauty Health (NASDAQ:SKIN) reported Q2 2024 GAAP EPS of $(0.10), missing the $(0.05) estimate. Sales were $90.6M, missing the $98.77M estimate. EPS decreased by 433.33% YoY, and sales decreased by 22.89% YoY.
August 08, 2024 | 9:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Beauty Health (NASDAQ:SKIN) reported disappointing Q2 2024 results with GAAP EPS of $(0.10) missing the $(0.05) estimate and sales of $90.6M missing the $98.77M estimate. EPS decreased by 433.33% YoY, and sales decreased by 22.89% YoY.
The significant miss on both EPS and sales estimates, along with the substantial YoY decreases in both metrics, is likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100